SGLT 2 INHIBITORS

Clinical trials for SGLT 2 INHIBITORS explained in plain language.

Never miss a new study

Get alerted when new SGLT 2 INHIBITORS trials appear

Sign up with your email to follow new studies for SGLT 2 INHIBITORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

Diabetes drug may fight inflammation after stent procedure

Knowledge-focused Recruiting now

This study tests whether empagliflozin, a diabetes drug, can reduce inflammation after a heart stent procedure. About 100 adults with stable coronary artery disease will take either empagliflozin or a placebo for three days before their scheduled stent placement. Researchers will…

Matched conditions: SGLT 2 INHIBITORS

Phase: PHASE4 • Sponsor: Hotel Dieu de France Hospital • Aim: Knowledge-focused

Last updated May 13, 2026 16:00 UTC

SGLT 2 INHIBITORS

Get alerted when new SGLT 2 INHIBITORS trials appear

Diabetes drug may fight inflammation after stent procedure